Form 4: CalciMedica CBO Plans Future Stock Purchase

Sentiment:

Insider Transaction Report 22 September 2025 9:35 AM

CalciMedica's Chief Business Officer, Eric W. Roberts, has filed a Form 4 indicating a planned purchase of 2,500 shares of common stock on September 18, 2025.

Better than expectedChief Business Officer Eric W. Roberts plans to acquire 2,500 shares of common stock, which is generally viewed as a positive signal of management's confidence in the company's valuation and future performance.

Summary

Eric W. Roberts, Chief Business Officer, Director, and 10% Owner of CalciMedica, Inc. (CALC), reported a planned acquisition of common stock.
The transaction, made pursuant to a Rule 10b5-1 plan, involves the purchase of 2,500 shares of common stock.
The shares are planned to be acquired at a price of $3.07 per share on September 18, 2025.
Following this planned transaction, Roberts' indirect beneficial ownership in an FMTC Custodian Roth IRA account will be 84,150 shares.
Total beneficial ownership across all direct and indirect holdings after this transaction will be 1,063,737 shares.

Sentiment

Score: 7

Explanation: The planned insider purchase by a key executive is a positive indicator of confidence, though the size of the transaction is moderate relative to total holdings. The 10b5-1 plan suggests a pre-determined strategy rather than an opportunistic buy.

Positives

A planned insider purchase by a key executive (Chief Business Officer) and director signals confidence in the company's future prospects.
The transaction is executed under a Rule 10b5-1 plan, indicating a pre-scheduled purchase rather than a reaction to immediate market events.

Future Outlook

Industry Context

This filing is specific to an individual's planned stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

Shareholders may view this planned insider purchase as a positive signal, potentially increasing investor confidence in CalciMedica's stock.

Key Dates

Date	Description
09/18/2025	Date of planned transaction for the acquisition of 2,500 shares of common stock.
09/22/2025	Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

The planned insider purchase by a Chief Business Officer is a positive signal, indicating management's confidence in the company's future. However, without additional financial or operational updates, this single transaction, while favorable, is typically not sufficient to warrant a 'buy' recommendation for a seasoned investor. It serves as a supportive data point for existing positions or further due diligence.

Keywords

CalciMedica, CALC, Insider Trading, Form 4, Stock Purchase, Eric W. Roberts, Chief Business Officer, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.